about
Sirtuin 1 (SIRT1) activation mediates sildenafil induced delayed cardioprotection against ischemia-reperfusion injury in miceInduction of microRNA-21 with exogenous hydrogen sulfide attenuates myocardial ischemic and inflammatory injury in miceDietary nitrate supplementation protects against Doxorubicin-induced cardiomyopathy by improving mitochondrial function.Long-acting phosphodiesterase-5 inhibitor tadalafil attenuates doxorubicin-induced cardiomyopathy without interfering with chemotherapeutic effect.Anti-inflammatory and cardioprotective effects of tadalafil in diabetic miceAdenosine A(1) receptor mediates delayed cardioprotective effect of sildenafil in mouse.Loss of myocardial ischemic postconditioning in adenosine A1 and bradykinin B2 receptors gene knockout miceEmerging new uses of phosphodiesterase-5 inhibitors in cardiovascular diseases.Cardioprotection with phosphodiesterase-5 inhibition--a novel preconditioning strategy.PDE5 inhibitors as therapeutics for heart disease, diabetes and cancerPharmacologic Inhibition of the NLRP3 Inflammasome Preserves Cardiac Function After Ischemic and Nonischemic Injury in the Mouse.Cinaciguat, a novel activator of soluble guanylate cyclase, protects against ischemia/reperfusion injury: role of hydrogen sulfide.Dietary inorganic nitrate alleviates doxorubicin cardiotoxicity: mechanisms and implications.Rapamycin protects against myocardial ischemia-reperfusion injury through JAK2-STAT3 signaling pathway.ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice.Mammalian target of rapamycin (mTOR) inhibition with rapamycin improves cardiac function in type 2 diabetic mice: potential role of attenuated oxidative stress and altered contractile protein expression.Reperfusion Therapy with Rapamycin Attenuates Myocardial Infarction through Activation of AKT and ERK.Relaxin' the Heart: A Novel Therapeutic Modality.Tumor-derived p53 mutants induce oncogenesis by transactivating growth-promoting genes.Par-4, a pro-apoptotic gene, inhibits radiation-induced NF kappa B activity and Bcl-2 expression leading to induction of radiosensitivity in human prostate cancer cells PC-3.Hydrogen sulfide mediates the cardioprotective effects of gene therapy with PKG-Iα.Protein kinase G-dependent cardioprotective mechanism of phosphodiesterase-5 inhibition involves phosphorylation of ERK and GSK3beta.mTOR Signaling in Cardiometabolic Disease, Cancer, and Aging.Phosphodiesterase-5 inhibition with sildenafil attenuates cardiomyocyte apoptosis and left ventricular dysfunction in a chronic model of doxorubicin cardiotoxicity.Protein kinase C plays an essential role in sildenafil-induced cardioprotection in rabbits.Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis. Essential role of nitric oxide signaling.Rapamycin confers preconditioning-like protection against ischemia-reperfusion injury in isolated mouse heart and cardiomyocytes.Cyclic GMP-dependent protein kinase Ialpha attenuates necrosis and apoptosis following ischemia/reoxygenation in adult cardiomyocyte.Protective effects of parecoxib, a cyclo-oxygenase-2 inhibitor, in postinfarction remodeling in the rat.Sildenafil (Viagra) attenuates ischemic cardiomyopathy and improves left ventricular function in mice.Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction.Interleukin-1 trap attenuates cardiac remodeling after experimental acute myocardial infarction in mice.Preconditioning by phosphodiesterase-5 inhibition improves therapeutic efficacy of adipose-derived stem cells following myocardial infarction in mice.Phosphodiesterase-5 inhibitor tadalafil attenuates oxidative stress and protects against myocardial ischemia/reperfusion injury in type 2 diabetic mice.Inhibition of mammalian target of rapamycin protects against reperfusion injury in diabetic heart through STAT3 signaling.Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism.Long-acting PDE5 inhibitor tadalafil prevents early doxorubicin-induced left ventricle diastolic dysfunction in juvenile mice: potential role of cytoskeletal proteins.Chronic treatment with novel nanoformulated micelles of rapamycin, Rapatar, protects diabetic heart against ischaemia/reperfusion injury.Metformin attenuates ER stress-induced mitochondrial dysfunction.Emerging Role of mTOR Signaling-Related miRNAs in Cardiovascular Diseases
P50
Q28539039-C3F40549-D7C8-401D-A488-C49FFBA7BE2DQ33874591-12A325D9-F40B-40B1-B818-F5C14C742707Q34022675-10CF4A3C-6C9C-4B2A-832E-44E6574D74F6Q34128868-381B9BE9-3928-4186-8BCA-912A7E3C58B0Q34428464-7CBCDBF9-C2A0-4FBC-BF6E-4B50B3D706FBQ34503360-3A27EF5E-2EB9-4575-AD49-035F02E9DA06Q34671472-6BA0B36C-A963-4EBA-B544-215A8B607426Q35500693-401E57B9-09AD-45FA-804A-761E9153EA93Q35661169-4345A8EC-6F0E-4F16-BDBE-AC58D1C9F453Q35827798-F99825C7-3789-4CDF-8577-99B3F980E1B6Q35847003-2E7FD6B0-1083-4DF7-9C6A-1F8A12C163BEQ35850118-4AF44793-DCF4-4BCB-9294-98FDEA04AD8FQ35989515-FAEA3775-96F2-4E24-9857-181AEFDBFF5CQ36392865-100F32FC-9C07-4EEE-90B4-D88606D61980Q37200237-5735388B-7B79-4BD5-A449-1AECA93C91BAQ37583506-D8F94787-D665-4661-B4C8-D5EADE296A57Q37714720-592EAFF1-0120-4772-A3CE-7AB8A78A0874Q38940630-B51EA313-BA1F-4802-83EA-C16C73C7A6BEQ40568020-FE256CA3-5FB3-43F4-AAFB-8AB91A0A854BQ40711642-8864CD13-B02C-4FBD-99E7-73A36FC8BA6DQ41189484-66D7AE55-21C6-48FE-B552-AA91F1793653Q41817597-5443BFA8-33CC-45C5-A1D1-96EF3C170617Q42336035-E4E6026C-7EA5-4AF5-9445-6E0E4F4D0CF8Q42476532-CCDA67B9-44C2-46A4-A34B-19E2CFB34C3FQ44799618-E0DEB2AA-9592-4445-BFD5-15C4B024B13BQ44907848-C167D521-6902-4623-9C4C-AC30D4DE2243Q44920860-2F69A8B3-D521-47CC-8DF9-278570A8D593Q44924018-97749C69-B6B0-4E89-A66F-44DF7CBAE8C0Q44933925-AE791E86-14D7-4DF3-8DBB-8B260A3E9B35Q44935527-3E4BFA82-1DBF-4ABB-898C-0EFAF1604252Q44938264-4D7C06E1-612D-416A-BB20-DDFAA89C490CQ44951942-77C63A2C-384C-48A2-9F2E-DEEA970D4421Q44970917-7C03FFEC-8F05-45CD-92D5-339F7BF1EE49Q44982851-E4A58C0B-D6B7-427E-A3D5-20DBBB510588Q45012762-7AC15B1A-4F54-44E6-AB15-7BBB72B49D84Q45050521-201C5CE1-336B-4E96-92EB-E2398EF056E9Q45053546-89E2021D-AD75-426C-8E3E-24DF44E252EBQ45068944-50F32FF7-4B15-4D00-AAD3-7933D03C161FQ45070301-B6F9486A-267C-4347-AFD2-366EF84C807FQ57300947-870CBA0A-301F-4B75-8816-0519E4E030B3
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Anindita Das
@ast
Anindita Das
@en
Anindita Das
@es
অনিন্দিতা দাস
@bn
type
label
Anindita Das
@ast
Anindita Das
@en
Anindita Das
@es
অনিন্দিতা দাস
@bn
prefLabel
Anindita Das
@ast
Anindita Das
@en
Anindita Das
@es
অনিন্দিতা দাস
@bn
P106
P31
P496
0000-0003-4422-7277